Level Four Advisory Services, LLC Cv Rx, Inc. Transaction History

Level Four Advisory Services, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$11.67 - $33.01 $21,519 - $60,870	1,844 Added 6.82%	28,885 $908,000
Q3 2023 Nov 13, 2023	SELL	$13.56 - $18.47 $187,806 - $255,809	-13,850 Reduced 33.87%	27,041 $410,000
Q2 2023 Jul 10, 2023	BUY	$8.57 - $15.44 $29,566 - $53,268	3,450 Added 9.21%	40,891 $631,000
Q1 2023 Jun 05, 2023	BUY	$7.08 - $19.4 $107,700 - $295,112	15,212 Added 68.43%	37,441 $348,000
Q4 2022 Feb 13, 2023	BUY	$8.94 - $18.35 $198,727 - $407,902	22,229 New	22,229 $407,000

13.5M

49.9K

2.1K

Ticker CVRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,576,200
Market Cap $178M
Description
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...

Get notified when there are updates to the investment portfolio of Level Four Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Level Four Advisory Services, LLC with notifications on news.